Price
333.35
+1.35%52W Range
Market Cap
₹318.08 Cr
Traded: ₹0.33 Cr (0.10%) 0.0x
Free Float: ₹91.77 Cr (0.36% of FF traded)
Volume · 60D trend
9.74 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -- | +3.0% | -1.0% | -- | -- | Decelerating |
| Return | -- | -29.0% | -3.0% | +3.0% | -- | Accelerating |
| Profit | -- | -46.0% | +30.0% | -- | +16.0% | Stable |
| Sales | -- | -7.0% | +10.0% | -- | +34.0% | Accelerating |
Quarterly Results
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Sep 2026PDF ↗ | Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 59 | 40 | 35 | 40 | 38 | 34 | 32 | 26 | 31 | 20 | 17 | 22 | 31 | 21 | 21 | 28 |
| Expenses | 53 | 37 | 41 | 36 | 34 | 35 | 31 | 30 | 34 | 23 | 21 | 27 | 30 | 24 | 25 | 29 |
| Operating Profit | 5 | 3 | -6 | 3 | 3 | -1 | 1 | -4 | -2 | -2 | -4 | -4 | 1 | -3 | -3 | -1 |
| Other Income | 1 | 2 | 1 | 2 | 2 | 3 | 2 | 1 | 3 | 6 | -1 | 6 | 3 | 3 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 6 | 4 | -6 | 5 | 5 | 1 | 2 | -3 | -0 | 3 | -6 | 1 | 4 | -1 | -2 | 0 |
| Tax % | 26.5% | 30.9% | 10.7% | 20.0% | 21.1% | 34.1% | -20.0% | -13.8% | 585.7% | 36.6% | -35.9% | 82.1% | 25.8% | -23.7% | -22.3% | -11.1% |
| Net Profit | 4 | 3 | -6 | 4 | 4 | 1 | 2 | -3 | -0 | 2 | -4 | 0 | 3 | -1 | -2 | 0 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 4.2 | 3.2 | -6.4 | 3.9 | 3.6 | 0.8 | 2.5 | -2.8 | -0.5 | 1.7 | -4.2 | 0.2 | 2.9 | -0.7 | -1.5 | 0.3 |
| Sales Growth (YoY) | 55.1% | 18.0% | 11.6% | 49.8% | 21.0% | 68.6% | 87.0% | 18.3% | -0.5% | -4.5% | -20.1% | -19.5% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 45.1% | 13.9% | -10.7% | 5.0% | 10.4% | 7.7% | 19.9% | -15.2% | 53.9% | 19.4% | -24.1% | -28.6% | 47.7% | 0.0% | -23.6% | -- |
| OP Growth (YoY) | 59.9% | 710.7% | -581.7% | 181.0% | 239.1% | 76.3% | 127.1% | 5.6% | -270.3% | 18.6% | -28.0% | -362.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | 52.9% | 159.2% | -277.8% | -0.6% | 683.9% | -146.7% | 129.9% | -70.6% | 0.4% | 46.7% | -4.2% | -408.0% | 147.6% | 16.2% | -276.1% | -- |
| Profit Growth (YoY) | 11.6% | 279.0% | -346.6% | 233.2% | 856.3% | -51.2% | 159.5% | -1747.1% | -116.6% | 333.8% | -171.2% | -43.3% | 200.0% | 83.0% | -9.0% | -94.0% |
| EPS Growth (YoY) | 16.8% | 297.5% | -358.3% | 239.6% | 856.3% | -51.2% | 159.5% | -1747.1% | -116.6% | 333.8% | -171.2% | -43.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 31.7% | 150.5% | -263.2% | 7.7% | 348.1% | -67.2% | 188.2% | -483.3% | -128.9% | 140.0% | -2541.2% | -94.1% | 507.0% | 53.6% | -610.0% | -- |
| OP Margin | 8.9% | 8.5% | -16.3% | 8.2% | 8.7% | -1.6% | 3.8% | -15.2% | -7.5% | -11.6% | -26.1% | -19.0% | 4.4% | -13.7% | -16.3% | -3.3% |
| Net Margin | 6.9% | 7.6% | -17.2% | 9.4% | 9.6% | 2.4% | 7.8% | -10.6% | -1.5% | 8.2% | -24.4% | 0.8% | 9.2% | -3.3% | -7.2% | 1.1% |
| Material Cost % | 66.0% | 61.0% | 61.0% | 64.0% | 63.0% | 65.0% | 60.0% | 63.0% | 65.0% | 60.0% | 66.0% | 71.0% | 61.0% | 68.0% | 67.0% | 60.0% |
| Employee Cost % | 7.0% | 11.0% | 12.0% | 11.0% | 11.0% | 13.0% | 13.0% | 15.0% | 12.0% | 18.0% | 18.0% | 15.0% | 10.0% | 13.0% | 13.0% | 14.0% |
| P/S | 1.83 | 1.95 | 1.83 | 1.57 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 66.80 | 71.52 | 143.38 | 21.83 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.76 | 1.65 | 1.49 | 1.13 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Copy of Newspaper Publication
Nureca records highest quarterly revenue in last 20 quarters ;Q2 revenue rises 55% to Rs. 58.53 crore .
Un-audited Financial results for the quarter and half year ended 30th September,2026
Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants ) Regulations ,2018.
Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2026 ,inter alia, to consider and approve inter-alia, the un-audited Financial ....
Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ("PIT Regulations")
Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ("PIT Regulations")
Closure of Trading Window
Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ("PIT Regulations")
Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations).
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Saurabh Goyal
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Smita Goyal
Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)
Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading ) Regulations ,2015 ("PIT Regulations ")
Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading )Regulations ,2015 (PIT Regulations )
Additional details required for Corporate Announcement under Regulation 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Pendency of Litigation(s)/disput(s) or the outcome impacting the Company.
Outcome and Proceedings of the 10th Annual General Meeting.
Scrutinizer Report and Voting Results for the 10th Annual General Meeting
Copy of Newspaper publication
Unaudited Financial results for the quarter ended June 30, 2026
Un-audited Financial Results for the quarter ended June 30, 2026.
Compliance certificate under Reg 74(5) of SEBI(DP) Regulations,2018
Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2026 ,inter alia, to consider and approve Nureca Limited has informed the exchange ....
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Saurabh Goyal
Resubmission of a More Legible Copy of the Notice of 10th Annual General Meeting ('AGM') and Annual Report 2025-26 submitted on 03 July 2026.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal Goyal
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Saurabh Goyal
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aryan Goyal
Nureca Limited has informed the exchange regarding newspaper publication.
Nureca Limited has informed the exchange regarding Annual Report for the FY 25-26.
Nureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ("PIT Regulations")
Nureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ("PIT Regulations")
Nureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ("PIT Regulations")
Nureca Limited has informed the exchange regarding Notice of 10th AGM of the company along with its Annual Report for the FY25-26.
Nureca Limited has informed the Exchange regarding Newspaper Publication.
Nureca Limited has informed the exchange regarding Resignation of Mr. Aryan Goyal from the position of Whole-time Director & CEO of the Company with effect from close of business hours ....
Nureca Limited has informed the exchange regarding Trading Window Closure .
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Nureca Limited has informed the Exchange regarding Press Release " Dr Trust 360 crosses 2.4 Million Users;Launches advanced AI Health Analytics "
Disclosure under Regulation 30 and Regulation 30 A read with Clauses 5 and 5A of Para A and Part A of Schedule III of Securities and Exchange Board of India ("SEBI") (Listing Obligations ....
Nureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of SEBI(PIT) Regulations ,2015.
Nureca Limited has informed the Exchange regarding no change in the aggregate shareholding of the Promoter and Promoter Group of the Company pursuant to inter se transfer of shares.
Nureca Limited has informed the exchange regarding Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ("PIT Regulations")
Nureca Limited has informed the Exchange regarding Corrigendum pursuant to the Outcome of the Board Meeting submitted on 29th May,2026.
Nureca Limited has informed the Exchange regarding Newspaper Publication.
Nureca Limited has informed the Exchange regarding Re-appointment of Internal Auditor for the FY 26-27 w.e.f. 01st April,2026 .
Nureca Limited has informed the exchange regarding the audited financial results for the quarter and financial year ended 31st March, 2026.